A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors with FGFR2b Overexpression (FORTITUDE 301)

  • Lipton, Lara (Primary Chief Investigator (PCI))
  • Spence, Anne (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date7/12/226/12/24

Keywords

  • Clinical Trials
  • FORTITUDE 301
  • Oncology